The UK records approximately 5,000 new cases of vulvar cancer annually, yet diagnostic delays remain a critical challenge in early detection. Recent research published in the British Journal of Obstetrics and Gynaecology reveals that 67% of vulvar cancer patients experience diagnostic delays exceeding three months, with itching present in 78% of cases but frequently misattributed to thrush or other benign conditions.
Cancer Research UK emphasizes that persistent vulvar itching lasting more than two weeks requires specialist evaluation, not self-medication. Incidence increases significantly with age, ranging from 3.2 cases per 100,000 women under 55 to 22.4 per 100,000 women aged 85 and above.
The stakes are substantial: the World Health Organization estimates that early detection could prevent up to 30% of cancer deaths globally, with five-year survival rates exceeding 90% for stage I vulvar cancer compared to 15% for advanced disease.
Read the full article on GMJ Newsroom.
Was this article helpful?
